The company is expecting 2025 EPS to range from $15.25 to $16.25, below the $16.33 FactSet consensus. Revenue is expected to decline by a mid-single-digit percent on a constant currency basis, as ...

While the continued erosion of Biogen’s multiple sclerosis franchise and weaker-than-expected 2025 guidance doesn’t seem to ...

NeuroOne Medical Technologies Corporation ( NASDAQ: NMTC) Q1 2025 Earnings Conference Call February 12, 2025 8:30 AM ET ...

Ketamine also has come under increasing scrutiny as a treatment recently, with studies suggesting that for some patients it ...

A child would need to eat 9,000 cookies in a day to approach harmful levels of pesticide or naturally occurring heavy metals.

While sleep supplements can be beneficial, the lack of regulation means consumers are not assured of a safe and effective ...

A number of counties are using opioid settlement money for child welfare purposes, but spending by Cameron County was ...

Gilead Sciences is rated a Strong Buy due to strong Q4 2024 results and a robust HIV franchise. Check out my 12-month price ...

The tragic early death of "Friends" star Matthew Perry from a ketamine overdose in 2023 has swung a spotlight on th ...

The pages that are set to be revived include information for patients about HIV testing and HIV prevention medication, ...

A federal judge on Tuesday ordered government agencies to restore public access to health-related webpages and datasets that ...

The American Society of Anesthesiologists has issued new guidance on ketamine administration for patients suffering from post-traumatic stress disorder, treatment-resistant depression and other mood ...